Venlafaxine with education and behavioral therapy for bladder pain
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether the antidepressant venlafaxine, combined with education and behavioral therapy, can reduce bladder pain and urinary symptoms in people with bladder pain syndrome (also called interstitial cystitis). It aims to find a new treatment option that may improve daily comfort and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with interstitial cystitis or bladder pain syndrome by a doctor
- You have had bladder or pelvic pain or urinary symptoms on most days in the past 3 months
- Your pain or urinary symptoms rated at least 3 out of 10 in the last 4 weeks
- You do not have conditions like a narrowed urethra, certain neurological diseases, autoimmune diseases, or a history of pelvic radiation or chemotherapy
- You are not pregnant or breastfeeding and are willing to avoid certain medications during the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called pregabalin, combined with educational and behavioral support, can reduce bladder pain and urinary symptoms in people with bladder pain syndrome (also called interstitial cystitis). It aims to see if this combination is safe and effective.
This trial tests whether adding mirogabalin to a special bladder treatment (EBMP) can reduce bladder pain and urinary symptoms in people with bladder pain syndrome/interstitial cystitis. It might help if you have ongoing bladder pain and a strong need to urinate often.
This study tests a new treatment (VNX001) for people with interstitial cystitis or bladder pain syndrome (IC/BPS). You must have already taken part in an earlier study of this drug to join. The goal is to see if it safely reduces bladder pain.
This study is testing if the type of pain you feel can help predict which treatments work best for interstitial cystitis (a condition that causes bladder pain and pressure). It may help match you with more effective care.
This Phase 2 trial tests VNX001 to see if it helps people with interstitial cystitis/bladder pain syndrome (IC/BPS) compared with its separate ingredients (lidocaine and heparin) or a placebo (inactive treatment). You may be eligible if you have had IC/BPS for months and recently had a moderate-to-severe bladder pain flare.
This trial tests whether a nerve-based therapy called EA can reduce bladder pain. It also aims to understand why the treatment may help by looking at underlying mechanisms.
Hear when a new Bladder Pain Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.